{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:32:10Z","timestamp":1794652330353,"version":"4.9.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-00944-x","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T01:20:27Z","timestamp":1747012827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cortical microstructural abnormalities in dementia with Lewy bodies and their associations with Alzheimer\u2019s disease copathologies"],"prefix":"10.1038","volume":"11","author":[{"given":"Elijah","family":"Mak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert I.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Przybelski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela J.","family":"Fought","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G.","family":"Lesnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1466-8357","authenticated-orcid":false,"given":"Christopher G.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9308-9275","authenticated-orcid":false,"given":"Matthew L.","family":"Senjem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheelakumari","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4286-0589","authenticated-orcid":false,"given":"Prashanthi","family":"Vemuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7916-622X","authenticated-orcid":false,"suffix":"Jr","given":"Clifford R.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1084-2469","authenticated-orcid":false,"given":"Hoon Ki","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toji","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4086-9598","authenticated-orcid":false,"given":"Leah K.","family":"Forsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Savica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Graff-Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4807-9833","authenticated-orcid":false,"given":"David T.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4390-685X","authenticated-orcid":false,"given":"Hugo","family":"Botha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik K.","family":"St. Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6544-066X","authenticated-orcid":false,"given":"David S.","family":"Knopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6591-8734","authenticated-orcid":false,"given":"Vijay K.","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7189-7917","authenticated-orcid":false,"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neill R.","family":"Graff-Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5133-5538","authenticated-orcid":false,"given":"Gregory S.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanis J.","family":"Ferman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8178-6601","authenticated-orcid":false,"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val J.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4153-8187","authenticated-orcid":false,"given":"Bradley F.","family":"Boeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0837-5080","authenticated-orcid":false,"given":"John T.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejal","family":"Kantarci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"944_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1017\/S0033291713000494","volume":"44","author":"SA Vann Jones","year":"2013","unstructured":"Vann Jones, S. A. & O\u2019Brien, J. T. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol. Med. 44, 673\u2013683 (2013).","journal-title":"Psychol. Med."},{"key":"944_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies. Neurology 89, 88\u2013100 (2017).","journal-title":"Neurology"},{"key":"944_CR3","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 65, 1863\u20131872 (2005).","journal-title":"Neurology"},{"key":"944_CR4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jalz.2017.09.014","volume":"14","author":"TJ Ferman","year":"2018","unstructured":"Ferman, T. J. et al. The limbic and neocortical contribution of \u03b1-Synuclein, tau, and amyloid \u03b2 to disease duration in dementia with Lewy bodies. Alzheimers Dement. 14, 330\u2013339 (2018).","journal-title":"Alzheimers Dement."},{"key":"944_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00401-015-1406-3","volume":"129","author":"L Walker","year":"2015","unstructured":"Walker, L. et al. Neuropathologically mixed Alzheimer\u2019s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol. 129, 729\u2013748 (2015).","journal-title":"Acta Neuropathol."},{"key":"944_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin, D. J. et al. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol. 16, 55\u201365 (2017).","journal-title":"Lancet Neurol."},{"key":"944_CR7","doi-asserted-by":"publisher","first-page":"e1182","DOI":"10.1212\/WNL.0000000000006212","volume":"91","author":"DW Dickson","year":"2018","unstructured":"Dickson, D. W. et al. APOE \u03b54 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology 91, e1182\u2013e1195 (2018).","journal-title":"Neurology"},{"key":"944_CR8","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00401-022-02421-8","volume":"143","author":"Y Jin","year":"2022","unstructured":"Jin, Y. et al. APOE4 exacerbates \u03b1-synuclein seeding activity and contributes to neurotoxicity in Alzheimer\u2019s disease with Lewy body pathology. Acta Neuropathol. 143, 641\u2013662 (2022).","journal-title":"Acta Neuropathol."},{"key":"944_CR9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1212\/WNL.0b013e31826357a5","volume":"79","author":"K Kantarci","year":"2012","unstructured":"Kantarci, K. et al. Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies. Neurology 79, 553\u2013560 (2012).","journal-title":"Neurology"},{"key":"944_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.neurobiolaging.2014.07.005","volume":"36","author":"Z Nedelska","year":"2015","unstructured":"Nedelska, Z. et al. Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Neurobiol. Aging 36, 452\u2013461 (2015).","journal-title":"Neurobiol. Aging"},{"key":"944_CR11","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/mds.28973","volume":"37","author":"Q Chen","year":"2022","unstructured":"Chen, Q. et al. Longitudinal Tau positron emission tomography in dementia with Lewy bodies. Mov. Disord. 37, 1256\u20131264 (2022).","journal-title":"Mov. Disord."},{"key":"944_CR12","doi-asserted-by":"crossref","unstructured":"Ferreira, D. et al. Cross-sectional associations of \u03b2-Amyloid, tau, and cerebrovascular biomarkers with neurodegeneration in probable dementia with lewy bodies. Neurology 100, e846\u2013e859 (2022).","DOI":"10.1212\/WNL.0000000000201579"},{"key":"944_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neurobiolaging.2018.09.004","volume":"73","author":"E Mak","year":"2019","unstructured":"Mak, E. et al. Beta amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies. Neurobiol. Aging 73, 74\u201381 (2019).","journal-title":"Neurobiol. Aging"},{"key":"944_CR14","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1093\/brain\/aww193","volume":"139","author":"L Sarro","year":"2016","unstructured":"Sarro, L. et al. Amyloid-\u03b2 deposition and regional grey matter atrophy rates in dementia with Lewy bodies. Brain J. Neurol. 139, 2740\u20132750 (2016).","journal-title":"Brain J. Neurol."},{"key":"944_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mds.25286","volume":"28","author":"H Shimada","year":"2012","unstructured":"Shimada, H. et al. \u03b2-amyloid in lewy body disease is related to Alzheimer\u2019s disease-like atrophy. Mov. Disord. 28, 169\u2013175 (2012).","journal-title":"Mov. Disord."},{"key":"944_CR16","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1093\/brain\/awt088","volume":"136","author":"P Merino-Serrais","year":"2013","unstructured":"Merino-Serrais, P. et al. The influence of phospho-tau on dendritic spines of cortical pyramidal neurons in patients with Alzheimer\u2019s disease. Brain 136, 1913\u20131928 (2013).","journal-title":"Brain"},{"key":"944_CR17","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/jmri.1076","volume":"13","author":"D Le Bihan","year":"2001","unstructured":"Le Bihan, D. et al. Diffusion tensor imaging: concepts and applications. J. Magn. Reson. Imaging 13, 534\u2013546 (2001).","journal-title":"J. Magn. Reson. Imaging"},{"key":"944_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.parkreldis.2016.01.003","volume":"24","author":"MJ Firbank","year":"2016","unstructured":"Firbank, M. J. et al. Longitudinal diffusion tensor imaging in dementia with Lewy bodies and Alzheimer\u2019s disease. Parkinsonism Relat. Disord. 24, 76\u201380 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"944_CR19","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1212\/WNL.0b013e3181e0f7cf","volume":"74","author":"K Kantarci","year":"2010","unstructured":"Kantarci, K. et al. Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI. Neurology 74, 1814\u20131821 (2010).","journal-title":"Neurology"},{"key":"944_CR20","unstructured":"Mak, E. et al. White matter neurite alterations in dementia with Lewy body bodies: influence of amyloid-\u03b2 and tau. Nat. Park. Dis. (2024)."},{"key":"944_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/alzrt248","volume":"6","author":"E Mak","year":"2014","unstructured":"Mak, E., Su, L., Williams, G. B. & O\u2019Brien, J. T. Neuroimaging characteristics of dementia with Lewy bodies. Alzheimers Res. Ther. 6, 18 (2014).","journal-title":"Alzheimers Res. Ther."},{"key":"944_CR22","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.neurobiolaging.2015.03.007","volume":"36","author":"Z Nedelska","year":"2015","unstructured":"Nedelska, Z. et al. White matter integrity in dementia with Lewy bodies: a voxel-based analysis of diffusion tensor imaging. Neurobiol. Aging 36, 2010\u20132017 (2015).","journal-title":"Neurobiol. Aging"},{"key":"944_CR23","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1212\/WNL.0b013e318266fc51","volume":"79","author":"R Watson","year":"2012","unstructured":"Watson, R. et al. Characterizing dementia with Lewy bodies by means of diffusion tensor imaging. Neurology 79, 906\u2013914 (2012).","journal-title":"Neurology"},{"key":"944_CR24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1017\/S1041610216002143","volume":"29","author":"E Mak","year":"2017","unstructured":"Mak, E. et al. Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its subfields in mild cognitive impairment, Alzheimer\u2019s disease, and dementia with Lewy bodies. Int. Psychogeriatr. 29, 545\u2013555 (2017).","journal-title":"Int. Psychogeriatr."},{"key":"944_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13195-015-0132-3","volume":"7","author":"PSJ Weston","year":"2015","unstructured":"Weston, P. S. J., Simpson, I. J. A., Ryan, N. S., Ourselin, S. & Fox, N. C. Diffusion imaging changes in grey matter in Alzheimer\u2019s disease: a potential marker of early neurodegeneration. Alzheimers Res. Ther. 7, 47 (2015).","journal-title":"Alzheimers Res. Ther."},{"key":"944_CR26","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13195-020-00679-2","volume":"12","author":"PSJ Weston","year":"2020","unstructured":"Weston, P. S. J. et al. Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer\u2019s disease. Alzheimers Res. Ther. 12, 112 (2020).","journal-title":"Alzheimers Res. Ther."},{"key":"944_CR27","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1212\/01.WNL.0000153076.46126.E9","volume":"64","author":"K Kantarci","year":"2005","unstructured":"Kantarci, K. et al. DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 64, 902\u2013904 (2005).","journal-title":"Neurology"},{"key":"944_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.nicl.2017.10.005","volume":"17","author":"J Henf","year":"2017","unstructured":"Henf, J., Grothe, M. J., Brueggen, K., Teipel, S. & Dyrba, M. Mean diffusivity in cortical gray matter in Alzheimer\u2019s disease: the importance of partial volume correction. Neuroimage Clin. 17, 579\u2013586 (2017).","journal-title":"Neuroimage Clin."},{"key":"944_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neuroimage.2012.06.081","volume":"73","author":"DK Jones","year":"2013","unstructured":"Jones, D. K., Kn\u00f6sche, T. R. & Turner, R. White matter integrity, fiber count, and other fallacies: the do\u2019s and don\u2019ts of diffusion MRI. NeuroImage 73, 239\u2013254 (2013).","journal-title":"NeuroImage"},{"key":"944_CR30","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.neuroimage.2012.03.072","volume":"61","author":"H Zhang","year":"2012","unstructured":"Zhang, H., Schneider, T., Wheeler-Kingshott, C. A. & Alexander, D. C. NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage 61, 1000\u20131016 (2012).","journal-title":"Neuroimage"},{"key":"944_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2021.118749","volume":"245","author":"CS Parker","year":"2021","unstructured":"Parker, C. S. et al. Not all voxels are created equal: reducing estimation bias in regional NODDI metrics using tissue-weighted means. Neuroimage 245, 118749 (2021).","journal-title":"Neuroimage"},{"key":"944_CR32","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/acn3.445","volume":"4","author":"F Grussu","year":"2017","unstructured":"Grussu, F. et al. Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?. Ann. Clin. Transl. Neurol. 4, 663\u2013679 (2017).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"944_CR33","doi-asserted-by":"publisher","first-page":"fcab106","DOI":"10.1093\/braincomms\/fcab106","volume":"3","author":"S Raghavan","year":"2021","unstructured":"Raghavan, S. et al. Diffusion models reveal white matter microstructural changes with ageing, pathology and cognition. Brain Commun. 3, fcab106 (2021).","journal-title":"Brain Commun."},{"key":"944_CR34","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.nicl.2014.04.008","volume":"4","author":"N Adluru","year":"2014","unstructured":"Adluru, N. et al. White matter microstructure in late middle-age: effects of apolipoprotein E4 and parental family history of Alzheimer\u2019s disease. Neuroimage Clin. 4, 730\u2013742 (2014).","journal-title":"Neuroimage Clin."},{"key":"944_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbas.2022.100030","volume":"2","author":"A Motovylyak","year":"2022","unstructured":"Motovylyak, A. et al. Age-related differences in white matter microstructure measured by advanced diffusion MRI in healthy older adults at risk for Alzheimer\u2019s disease. Aging Brain 2, 100030 (2022).","journal-title":"Aging Brain"},{"key":"944_CR36","doi-asserted-by":"publisher","first-page":"fcad351","DOI":"10.1093\/braincomms\/fcad351","volume":"6","author":"E Mak","year":"2024","unstructured":"Mak, E. et al. APOE \u025b4 exacerbates age-dependent deficits in cortical microstructure. Brain Commun. 6, fcad351 (2024).","journal-title":"Brain Commun."},{"key":"944_CR37","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1002\/hbm.24056","volume":"39","author":"TD Parker","year":"2018","unstructured":"Parker, T. D. et al. Cortical microstructure in young onset Alzheimer\u2019s disease using neurite orientation dispersion and density imaging. Hum. Brain Mapp. 39, 3005\u20133017 (2018).","journal-title":"Hum. Brain Mapp."},{"key":"944_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neurobiolaging.2023.12.001","volume":"134","author":"N Corriveau-Lecavalier","year":"2024","unstructured":"Corriveau-Lecavalier, N. et al. Neurite-based white matter alterations in MAPT mutation carriers: a multi-shell diffusion MRI study in the ALLFTD consortium. Neurobiol. Aging 134, 135\u2013145 (2024).","journal-title":"Neurobiol. Aging"},{"key":"944_CR39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neurobiolaging.2021.01.016","volume":"101","author":"E Mak","year":"2021","unstructured":"Mak, E. et al. In vivo coupling of dendritic complexity with presynaptic density in primary tauopathies. Neurobiol. Aging 101, 187\u2013198 (2021).","journal-title":"Neurobiol. Aging"},{"key":"944_CR40","volume":"14","author":"P Maillard","year":"2022","unstructured":"Maillard, P. et al. MRI free water as a biomarker for cognitive performance: validation in the MarkVCID consortium. Alzheimers Dement. Diagn. Assess. Dis. Monit. 14, e12362 (2022).","journal-title":"Alzheimers Dement. Diagn. Assess. Dis. Monit."},{"key":"944_CR41","doi-asserted-by":"publisher","first-page":"101985","DOI":"10.1016\/j.nicl.2019.101985","volume":"24","author":"E Ofori","year":"2019","unstructured":"Ofori, E. et al. Free-water imaging of the hippocampus is a sensitive marker of Alzheimer\u2019s disease. Neuroimage Clin. 24, 101985 (2019).","journal-title":"Neuroimage Clin."},{"key":"944_CR42","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/mrm.22055","volume":"62","author":"O Pasternak","year":"2009","unstructured":"Pasternak, O., Sochen, N., Gur, Y., Intrator, N. & Assaf, Y. Free water elimination and mapping from diffusion MRI. Magn. Reson. Med. 62, 717\u2013730 (2009).","journal-title":"Magn. Reson. Med."},{"key":"944_CR43","doi-asserted-by":"publisher","first-page":"108908","DOI":"10.1016\/j.jneumeth.2020.108908","volume":"346","author":"K Kamiya","year":"2020","unstructured":"Kamiya, K., Hori, M. & Aoki, S. NODDI in clinical research. J. Neurosci. Methods 346, 108908 (2020).","journal-title":"J. Neurosci. Methods"},{"key":"944_CR44","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1093\/cercor\/bhz286","volume":"30","author":"NM Vogt","year":"2020","unstructured":"Vogt, N. M. et al. Cortical microstructural alterations in mild cognitive impairment and Alzheimer\u2019s disease dementia. Cereb. Cortex 30, 2948\u20132960 (2020).","journal-title":"Cereb. Cortex"},{"key":"944_CR45","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1093\/brain\/awx275","volume":"140","author":"M Colom-Cadena","year":"2017","unstructured":"Colom-Cadena, M. et al. Synaptic phosphorylated \u03b1-synuclein in dementia with Lewy bodies. Brain J. Neurol. 140, 3204\u20133214 (2017).","journal-title":"Brain J. Neurol."},{"key":"944_CR46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/1533317507310565","volume":"23","author":"GJ Revuelta","year":"2008","unstructured":"Revuelta, G. J., Rosso, A. & Lippa, C. F. Neuritic pathology as a correlate of synaptic loss in dementia with Lewy bodies. Am. J. Alzheimers Dis. Other Demen. 23, 97\u2013102 (2008).","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"944_CR47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure, M. A. & Dickson, D. W. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol. Neurodegener. 14, 32 (2019).","journal-title":"Mol. Neurodegener."},{"key":"944_CR48","doi-asserted-by":"publisher","first-page":"102754","DOI":"10.1016\/j.nicl.2021.102754","volume":"31","author":"K Kantarci","year":"2021","unstructured":"Kantarci, K. et al. FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD. Neuroimage Clin. 31, 102754 (2021).","journal-title":"Neuroimage Clin."},{"key":"944_CR49","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fnagi.2015.00208","volume":"7","author":"S Delli Pizzi","year":"2015","unstructured":"Delli Pizzi, S. et al. Structural connectivity is differently altered in dementia with Lewy body and Alzheimer\u2019s disease. Front. Aging Neurosci. 7, 208 (2015).","journal-title":"Front. Aging Neurosci."},{"key":"944_CR50","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.nicl.2018.06.020","volume":"19","author":"Z Nedelska","year":"2018","unstructured":"Nedelska, Z. et al. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: associations with clinical severity, glucose metabolism and tau PET. Neuroimage Clin. 19, 939\u2013947 (2018).","journal-title":"Neuroimage Clin."},{"key":"944_CR51","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","volume":"73","author":"SN Gomperts","year":"2016","unstructured":"Gomperts, S. N. et al. Tau positron emission tomographic imaging in the Lewy body diseases. JAMA Neurol. 73, 1334 (2016).","journal-title":"JAMA Neurol."},{"key":"944_CR52","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ana.24825","volume":"81","author":"K Kantarci","year":"2016","unstructured":"Kantarci, K. et al. AV-1451 tau and \u03b2-Amyloid positron emission tomography imaging in dementia with Lewy bodies. Ann. Neurol. 81, 58\u201367 (2016).","journal-title":"Ann. Neurol."},{"key":"944_CR53","doi-asserted-by":"publisher","first-page":"e0153404","DOI":"10.1371\/journal.pone.0153404","volume":"11","author":"F Deligianni","year":"2016","unstructured":"Deligianni, F., Carmichael, D. W., Zhang, G. H., Clark, C. A. & Clayden, J. D. NODDI and tensor-based microstructural indices as predictors of functional connectivity. PLoS ONE 11, e0153404 (2016).","journal-title":"PLoS ONE"},{"key":"944_CR54","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1523\/JNEUROSCI.3979-14.2015","volume":"35","author":"A Nazeri","year":"2015","unstructured":"Nazeri, A. et al. Functional consequences of neurite orientation dispersion and density in humans across the adult lifespan. J. Neurosci. 35, 1753\u20131762 (2015).","journal-title":"J. Neurosci."},{"key":"944_CR55","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.neuroimage.2018.02.017","volume":"182","author":"H Fukutomi","year":"2018","unstructured":"Fukutomi, H. et al. Neurite imaging reveals microstructural variations in human cerebral cortical gray matter. Neuroimage 182, 488\u2013499 (2018).","journal-title":"Neuroimage"},{"key":"944_CR56","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1212\/01.wnl.0000216137.09685.c1","volume":"66","author":"S Zaja-Milatovic","year":"2006","unstructured":"Zaja-Milatovic, S. et al. Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies. Neurology 66, 1591\u20131593 (2006).","journal-title":"Neurology"},{"key":"944_CR57","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy, J. A. & Higgins, G. A. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science 256, 184\u2013185 (1992).","journal-title":"Science"},{"key":"944_CR58","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack","year":"2013","unstructured":"Jack, C. R. et al. Update on hypothetical model of Alzheimer\u2019s disease biomarkers. Lancet Neurol. 12, 207\u2013216 (2013).","journal-title":"Lancet Neurol."},{"key":"944_CR59","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi, Y. et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523\u2013527 (2017).","journal-title":"Nature"},{"key":"944_CR60","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1083\/jcb.200108057","volume":"156","author":"K Stamer","year":"2002","unstructured":"Stamer, K., Vogel, R., Thies, E., Mandelkow, E. & Mandelkow, E.-M. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 156, 1051\u20131063 (2002).","journal-title":"J. Cell Biol."},{"key":"944_CR61","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1002\/alz.13693","volume":"20","author":"JC DeSimone","year":"2024","unstructured":"DeSimone, J. C. et al. Diffusion MRI relates to plasma A\u03b242\/40 in PET negative participants without dementia. Alzheimers Dement. 20, 2830\u20132842 (2024).","journal-title":"Alzheimers Dement."},{"key":"944_CR62","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/glia.20306","volume":"53","author":"JM Craft","year":"2006","unstructured":"Craft, J. M., Watterson, D. M. & Van Eldik, L. J. Human amyloid beta-induced neuroinflammation is an early event in neurodegeneration. Glia 53, 484\u2013490 (2006).","journal-title":"Glia"},{"key":"944_CR63","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41582-018-0054-3","volume":"14","author":"BF Boeve","year":"2018","unstructured":"Boeve, B. F. & Kantarci, K. Multimodal imaging in RBD - present and future. Nat. Rev. Neurol. 14, 574\u2013576 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"944_CR64","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1523\/JNEUROSCI.2028-17.2017","volume":"38","author":"A Maass","year":"2018","unstructured":"Maass, A. et al. Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging. J. Neurosci. 38, 530\u2013543 (2018).","journal-title":"J. Neurosci."},{"key":"944_CR65","first-page":"678","volume":"10","author":"E Mak","year":"2018","unstructured":"Mak, E. et al. In vivo coupling of tau pathology and cortical thinning in Alzheimer\u2019s disease. Alzheimers Dement. Diagn. Assess. Dis. Monit. 10, 678\u2013687 (2018).","journal-title":"Alzheimers Dement. Diagn. Assess. Dis. Monit."},{"key":"944_CR66","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neurobiolaging.2017.04.024","volume":"56","author":"K Kantarci","year":"2017","unstructured":"Kantarci, K. et al. White matter integrity on DTI and the pathologic staging of Alzheimer\u2019s disease. Neurobiol. Aging 56, 172\u2013179 (2017).","journal-title":"Neurobiol. Aging"},{"key":"944_CR67","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jamaneurol.2014.1482","volume":"71","author":"K Kantarci","year":"2014","unstructured":"Kantarci, K. et al. White matter integrity determined with diffusion tensor imaging in older adults without dementia. JAMA Neurol. 71, 1547 (2014).","journal-title":"JAMA Neurol."},{"key":"944_CR68","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley, L. A. et al. Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 57\u201371 (2011).","journal-title":"Neuron"},{"key":"944_CR69","doi-asserted-by":"publisher","first-page":"716","DOI":"10.15252\/emmm.201607305","volume":"9","author":"S Blumenstock","year":"2017","unstructured":"Blumenstock, S. et al. Seeding and transgenic overexpression of alpha-synuclein triggers dendritic spine pathology in the neocortex. EMBO Mol. Med. 9, 716\u2013731 (2017).","journal-title":"EMBO Mol. Med."},{"key":"944_CR70","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/jnen\/62.4.389","volume":"62","author":"T Ishizawa","year":"2003","unstructured":"Ishizawa, T., Mattila, P., Davies, P., Wang, D. & Dickson, D. W. Colocalization of tau and alpha-synuclein epitopes in lewy bodies. J. Neuropathol. Exp. Neurol. 62, 389\u2013397 (2003).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"944_CR71","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.1082324","volume":"300","author":"BI Giasson","year":"2003","unstructured":"Giasson, B. I. et al. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300, 636\u2013640 (2003).","journal-title":"Science"},{"key":"944_CR72","doi-asserted-by":"crossref","unstructured":"Moussaud, S. et al. Alpha-synuclein and tau: teammates in neurodegeneration? Mol. Neurodegener. 9, 43 (2014).","DOI":"10.1186\/1750-1326-9-43"},{"key":"944_CR73","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","volume":"9","author":"L Pantoni","year":"2010","unstructured":"Pantoni, L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 9, 689\u2013701 (2010).","journal-title":"Lancet Neurol."},{"key":"944_CR74","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1212\/WNL.0b013e3182a43e45","volume":"81","author":"D Erten-Lyons","year":"2013","unstructured":"Erten-Lyons, D. et al. Neuropathologic basis of white matter hyperintensity accumulation with advanced age. Neurology 81, 977\u2013983 (2013).","journal-title":"Neurology"},{"key":"944_CR75","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/mds.27100","volume":"32","author":"E Ofori","year":"2017","unstructured":"Ofori, E. et al. Free-water improves detection of changes in the substantia nigra in parkinsonism: a multi-site study. Mov. Disord. 32, 1457\u20131464 (2017).","journal-title":"Mov. Disord."},{"key":"944_CR76","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/brain\/awy265","volume":"141","author":"A Surendranathan","year":"2018","unstructured":"Surendranathan, A. et al. Early microglial activation and peripheral inflammation in dementia with Lewy bodies. Brain J. Neurol. 141, 3415\u20133427 (2018).","journal-title":"Brain J. Neurol."},{"key":"944_CR77","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jalz.2016.07.003","volume":"13","author":"L Sarro","year":"2016","unstructured":"Sarro, L. et al. An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer\u2019s disease. Alzheimers Dement. 13, 257\u2013266 (2016).","journal-title":"Alzheimers Dement."},{"key":"944_CR78","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/ana.22245","volume":"69","author":"C Scherfler","year":"2011","unstructured":"Scherfler, C. et al. White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study. Ann. Neurol. 69, 400\u2013407 (2011).","journal-title":"Ann. Neurol."},{"key":"944_CR79","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1212\/WNL.0000000000009763","volume":"95","author":"TJ Ferman","year":"2020","unstructured":"Ferman, T. J. et al. Subtypes of dementia with Lewy bodies are associated with \u03b1-synuclein and tau distribution. Neurology 95, e155\u2013e165 (2020).","journal-title":"Neurology"},{"key":"944_CR80","doi-asserted-by":"publisher","first-page":"P05.050","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.P05.050","volume":"78","author":"M Murray","year":"2012","unstructured":"Murray, M. et al. RBD Is Associated with reduced Alzheimer\u2019s pathology in dementia with Lewy bodies (P05.050). Neurology 78, P05.050\u2013P05.050 (2012).","journal-title":"Neurology"},{"key":"944_CR81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-023-00614-w","volume":"10","author":"A Habich","year":"2024","unstructured":"Habich, A. et al. Grey matter networks in women and men with dementia with Lewy bodies. Npj Park. Dis. 10, 1\u20139 (2024).","journal-title":"Npj Park. Dis."},{"key":"944_CR82","doi-asserted-by":"publisher","first-page":"e1916439","DOI":"10.1001\/jamanetworkopen.2019.16439","volume":"2","author":"Z Nedelska","year":"2019","unstructured":"Nedelska, Z. et al. Association of longitudinal \u03b2-amyloid accumulation determined by positron emission tomography with clinical and cognitive decline in adults with probable Lewy body dementia. JAMA Netw. Open 2, e1916439 (2019).","journal-title":"JAMA Netw. Open"},{"key":"944_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04268-8","volume":"9","author":"E Gen\u00e7","year":"2018","unstructured":"Gen\u00e7, E. et al. Diffusion markers of dendritic density and arborization in gray matter predict differences in intelligence. Nat. Commun. 9, 1905 (2018).","journal-title":"Nat. Commun."},{"key":"944_CR84","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neurobiolaging.2020.11.006","volume":"101","author":"E Mak","year":"2021","unstructured":"Mak, E. et al. Imaging tau burden in dementia with Lewy bodies using [18F]-AV1451 positron emission tomography. Neurobiol. Aging 101, 172\u2013180 (2021).","journal-title":"Neurobiol. Aging"},{"key":"944_CR85","doi-asserted-by":"crossref","unstructured":"Shim, K. H., Kang, M. J., Youn, Y. C., An, S. S. A. & Kim, S. Alpha-synuclein: a pathological factor with A\u03b2 and tau and biomarker in Alzheimer\u2019s disease. Alzheimers Res. Ther. 14, 201 (2022).","DOI":"10.1186\/s13195-022-01150-0"},{"key":"944_CR86","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1016\/j.cell.2023.06.018","volume":"186","author":"K Kantarci","year":"2023","unstructured":"Kantarci, K. Toward imaging of alpha-synuclein with PET. Cell 186, 3327\u20133329 (2023).","journal-title":"Cell"},{"key":"944_CR87","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1474-4422(20)30449-X","volume":"20","author":"A Iranzo","year":"2021","unstructured":"Iranzo, A. et al. Detection of \u03b1-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study. Lancet Neurol. 20, 203\u2013212 (2021).","journal-title":"Lancet Neurol."},{"key":"944_CR88","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith, I. G. et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology 94, 743\u2013755 (2020).","journal-title":"Neurology"},{"key":"944_CR89","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein, M. F., Folstein, S. E. & McHugh, P. R. Mini-mental state. J. Psychiatr. Res. 12, 189\u2013198 (1975).","journal-title":"J. Psychiatr. Res."},{"key":"944_CR90","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1212\/WNL.62.2.181","volume":"62","author":"TJ Ferman","year":"2004","unstructured":"Ferman, T. J. et al. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology 62, 181\u2013187 (2004).","journal-title":"Neurology"},{"key":"944_CR91","unstructured":"American Academy of Sleep Medicine. Classification of Sleep Disorders, Second Edition (ICSD-2). (American Academy of Sleep Medicine, 2005)."},{"key":"944_CR92","doi-asserted-by":"publisher","first-page":"475","DOI":"10.5664\/jcsm.2670","volume":"09","author":"BF Boeve","year":"2013","unstructured":"Boeve, B. F. et al. Validation of the mayo sleep questionnaire to screen for REM sleep behavior disorder in a community-based sample. J. Clin. Sleep. Med. 09, 475\u2013480 (2013).","journal-title":"J. Clin. Sleep. Med."},{"key":"944_CR93","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000115751","volume":"30","author":"RO Roberts","year":"2008","unstructured":"Roberts, R. O. et al. The Mayo clinic study of aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology 30, 58\u201369 (2008).","journal-title":"Neuroepidemiology"},{"key":"944_CR94","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1212\/WNL.0000000000207393","volume":"101","author":"P Diaz-Galvan","year":"2023","unstructured":"Diaz-Galvan, P. et al. \u03b2-amyloid load on PET along the continuum of dementia with Lewy bodies. Neurology 101, e178\u2013e188 (2023).","journal-title":"Neurology"},{"key":"944_CR95","unstructured":"Reid, R. I. et al. Diffusion specific segmentation: skull stripping with diffusion MRI data alone. In Computational Diffusion MRI MICCAI Workshop (Springer International Publishing, 2018)."},{"key":"944_CR96","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.neuroimage.2016.08.016","volume":"142","author":"J Veraart","year":"2016","unstructured":"Veraart, J. et al. Denoising of diffusion MRI using random matrix theory. Neuroimage 142, 394\u2013406 (2016).","journal-title":"Neuroimage"},{"key":"944_CR97","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.neuroimage.2015.10.019","volume":"125","author":"JLR Andersson","year":"2016","unstructured":"Andersson, J. L. R. & Sotiropoulos, S. N. An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging. Neuroimage 125, 1063\u20131078 (2016).","journal-title":"Neuroimage"},{"key":"944_CR98","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/mrm.26054","volume":"76","author":"E Kellner","year":"2015","unstructured":"Kellner, E., Dhital, B., Kiselev, V. G. & Reisert, M. Gibbs-ringing artifact removal based on local subvoxel-shifts. Magn. Reson. Med. 76, 1574\u20131581 (2015).","journal-title":"Magn. Reson. Med."},{"key":"944_CR99","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jmr.2008.11.015","volume":"197","author":"CG Koay","year":"2009","unstructured":"Koay, C. G., Ozarslan, E. & Basser, P. J. A signal-transformational framework for breaking the noise floor and its applications in MRI. J. Magn. Reson. 197, 108\u2013119 (2009).","journal-title":"J. Magn. Reson."},{"key":"944_CR100","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neuroimage.2014.10.026","volume":"105","author":"A Daducci","year":"2015","unstructured":"Daducci, A. et al. Accelerated microstructure imaging via convex optimization (AMICO) from diffusion MRI data. Neuroimage 105, 32\u201344 (2015).","journal-title":"Neuroimage"},{"key":"944_CR101","doi-asserted-by":"crossref","unstructured":"Schwarz, C. G. et al. [P2\u2013415]: the Mayo clinic adult lifespan template: better quantification across the lifespan. Alzheimers Dement. 13, P792\u2013P792 (2017).","DOI":"10.1016\/j.jalz.2017.06.1071"},{"key":"944_CR102","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.neuroimage.2010.09.025","volume":"54","author":"BB Avants","year":"2011","unstructured":"Avants, B. B. et al. A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage 54, 2033\u20132044 (2011).","journal-title":"Neuroimage"},{"key":"944_CR103","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1093\/brain\/awz268","volume":"142","author":"CR Jack","year":"2019","unstructured":"Jack, C. R. et al. The bivariate distribution of amyloid-\u03b2 and tau: relationship with established neurocognitive clinical syndromes. Brain J. Neurol. 142, 3230\u20133242 (2019).","journal-title":"Brain J. Neurol."},{"key":"944_CR104","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.mri.2009.01.006","volume":"27","author":"J Ashburner","year":"2009","unstructured":"Ashburner, J. Computational anatomy with the SPM software. Magn. Reson. Imaging 27, 1163\u20131174 (2009).","journal-title":"Magn. Reson. Imaging"},{"key":"944_CR105","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1212\/WNL.0b013e3182840c9f","volume":"80","author":"L Raz","year":"2013","unstructured":"Raz, L. et al. Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women. Neurology 80, 911\u2013918 (2013).","journal-title":"Neurology"}],"updated-by":[{"DOI":"10.1038\/s41531-025-01068-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000}}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-00944-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-00944-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-00944-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:31:01Z","timestamp":1757172661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-00944-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["944"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-00944-x","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41531-025-01068-y","asserted-by":"object"}]},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41531-025-01068-y","URL":"https:\/\/doi.org\/10.1038\/s41531-025-01068-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E. Mak, R.I. Reid, S.A. Przybelski, A.J. Fought, and T.G. Lesnick report no disclosures relevant to the manuscript. C.G. Schwarz receives research support from the NIH. J. Graff-Radford serves on the editorial board for Neurology and receives research support from NIH. M.L. Senjem owns or has owned stock in medical-related companies, unrelated to the current work, within the past 36 months: Align Technology, Inc., Inovio Pharmaceuticals, Inc., Mesa Laboratories, Inc., Johnson and Johnson, LHC Group, Inc., Natus Medical Inc., and Varex Imaging Corporation. J.A. Fields reports no disclosures relevant to the manuscript. D.S. Knopman serves on a Data Safety Monitoring Board for the DIAN study, has served on a Data Safety Monitoring Board for a tau therapeutic for Biogen but received no personal compensation, is a site investigator in Biogen aducanumab trials, is an investigator in clinical trials sponsored by Lilly Pharmaceuticals and the University of Southern California, serves as a consultant for Samus Therapeutics, Roche, Magellan Health and Alzeca Biosciences but receives no personal compensation, and receives research support from the NIH. D.T. Jones reports no disclosures relevant to the manuscript. R. Savica reports no disclosures relevant to the manuscript. V.K. Ramanan receives research funding from the NIH and the Mangurian Foundation for Lewy Body disease research and has provided educational content for Medscape unrelated to this work. T. Ferman receives funding from the Mangurian Foundation for Lewy body research and NIH. NR Graff-Radford reports no disclosures relevant to the manuscript. V.J. Lowe serves as a consultant for Bayer Schering Pharma, Piramal Life Sciences, Life Molecular Imaging, Eisai Inc., AVID Radiopharmaceuticals, and Merck Research and receives research support from GE Healthcare, Siemens Molecular Imaging, AVID Radiopharmaceuticals, and the NIH (NIA, NCI). Clifford R. Jack Jr. is employed by Mayo Clinic. He receives grant funding from the National Institutes of Health (R37 AG011378, R01 AG041851), the Alexander family professorship and the GHR Foundation. Within the past 36 months, he served on a DSMB for Roche pro bono; no payments to the individual or institution were involved. He has received funding from the Alzheimer\u2019s Association for travel to scientific meetings. R.C. Petersen serves as a consultant for Roche, Inc., Merck, Inc., Biogen, Inc., Eisai, Inc., Genentech, Inc., and Nestle, Inc., served on a DSMB for Genentech, receives royalties from Oxford University Press and UpToDate, and receives NIH funding. B.F. Boeve has served as an investigator for clinical trials sponsored by Alector, Cognition Therapeutics, EIP Pharma, and Transposon. He serves on the Scientific Advisory Board of the Tau Consortium\u2014funded by the Rainwater Charitable Foundation. He receives research support from NIH, the Mayo Clinic Dorothy and Harry T. Mangurian Jr. Lewy Body Dementia Program, the Little Family Foundation, and the Ted Turner and Family Foundation. E.K. Louis has no disclosures related to this work. He has served as a Co-Investigator on K. Kantarci research grant (DLB U01) and as a NAPS co-investigator. J.T. O\u2019Brien. has no conflicts related to this study; unrelated to this work he has received honoraria for work as DSMB chair or member for TauRx, Axon, Eisai, has acted as a consultant for Roche, and has received research support from Alliance Medical and Merck. K. Kantarci consults for Biogen, receives research support from Avid Radiopharmaceuticals and Eli Lilly, and receives funding from NIH and Alzheimer\u2019s Drug Discovery Foundation. GS Day reports no competing interests directly relevant to this work. His research is supported by NIH (K23AG064029, U01AG057195, U01NS120901, U19AG032438). He serves as a consultant for Parabon Nanolabs Inc and as a Topic Editor (Dementia) for DynaMed (EBSCO). He is the co-Project PI for a clinical trial in anti-NMDAR encephalitis, which receives support from NINDS (U01NS120901) and Amgen Pharmaceuticals; and a consultant for Arialys Therapeutics. He has developed educational materials for Continuing Education Inc and Ionis Pharmaceutical. He owns stock in ANI pharmaceuticals. Dr. Day\u2019s institution has received support from Eli Lilly for development and participation in an educational event promoting early diagnosis of symptomatic Alzheimer disease, and in-kind contributions of radiotracer precursors for tau-PET neuroimaging in studies of memory and aging (via Avid Radiopharmaceuticals, a wholly owned subsidiary of Eli Lilly).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}